Log in
OTCMKTS:NPHC

Nutra Pharma Stock Forecast, Price & News

$0.0006
0.00 (0.00 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.01
Volume24.64 million shs
Average Volume6.63 million shs
Market Capitalization$2.41 million
P/E RatioN/A
Dividend YieldN/A
Beta3.96
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating back pain, neck pain, headaches, joint pain, migraines, and neuralgia, as well as a topical gel for treating joint pain, neck pain, arthritis pain, and pain associated with repetitive stress; Pet Pain-Away, an over-the-counter pain reliever to treat pain in cats and dogs; Luxury Feet, an over-the-counter pain reliever to treat foot pain from high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Nyloxin, a topical therapy for chronic pain in horses. It is also developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases, including human immunodeficiency virus/AIDS and herpes; RPI-78 for pain and arthritis; and RPI-70 for pain. The company has a collaboration agreement with the International Security Group to develop nerve agent counter measures. Nutra Pharma Corp. was founded in 2000 and is based in Coral Springs, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.78 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NPHC
CUSIPN/A
Phone954-509-0911

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$120,000.00

Profitability

Miscellaneous

Employees4
Outstanding Shares4,020,246,000
Market Cap$2.41 million
Next Earnings DateN/A
OptionableNot Optionable
$0.0006
0.00 (0.00 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NPHC News and Ratings via Email

Sign-up to receive the latest news and ratings for NPHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Nutra Pharma (OTCMKTS:NPHC) Frequently Asked Questions

How has Nutra Pharma's stock been impacted by COVID-19?

Nutra Pharma's stock was trading at $0.0008 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NPHC stock has decreased by 25.0% and is now trading at $0.0006.
View which stocks have been most impacted by COVID-19
.

How were Nutra Pharma's earnings last quarter?

Nutra Pharma Corp. (OTCMKTS:NPHC) issued its earnings results on Friday, August, 17th. The company reported $0.00 EPS for the quarter. The business had revenue of $0.03 million for the quarter.
View Nutra Pharma's earnings history
.

Are investors shorting Nutra Pharma?

Nutra Pharma saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 14,000 shares, a decrease of 86.2% from the August 31st total of 101,700 shares. Based on an average trading volume of 26,121,600 shares, the days-to-cover ratio is presently 0.0 days.
View Nutra Pharma's Short Interest
.

Who are some of Nutra Pharma's key competitors?

What other stocks do shareholders of Nutra Pharma own?

Who are Nutra Pharma's key executives?

Nutra Pharma's management team includes the following people:
  • Mr. Erik J. Deitsch, Chairman, CEO, Pres & CFO (Age 51)
  • Dr. Dale VanderPutten, Chief Scientific Officer (Age 60)
  • Mr. Neil Roth, Pres of Designer Diagnostics, Inc
  • Ms. Nina Goldstein, Sec. (Age 59)

What is Nutra Pharma's stock symbol?

Nutra Pharma trades on the OTCMKTS under the ticker symbol "NPHC."

How do I buy shares of Nutra Pharma?

Shares of NPHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nutra Pharma's stock price today?

One share of NPHC stock can currently be purchased for approximately $0.00.

How big of a company is Nutra Pharma?

Nutra Pharma has a market capitalization of $2.41 million and generates $120,000.00 in revenue each year. Nutra Pharma employs 4 workers across the globe.

What is Nutra Pharma's official website?

The official website for Nutra Pharma is www.nutrapharma.com.

How can I contact Nutra Pharma?

Nutra Pharma's mailing address is 12538 WEST ATLANTIC BLVD., CORAL SPRINGS FL, 33071. The company can be reached via phone at 954-509-0911 or via email at [email protected]

This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.